Aptose Biosciences Inc.
Aryl imidazoles for treatment of cancer

Last updated:

Abstract:

The present invention relates to a method of preventing, reducing, or treating cancer in a subject, comprising administering a therapeutically effective amount of ##STR00001## or a pharmaceutically acceptable salt, free base, hydrate, complex, or chelate (including metal chelates, such as iron, zinc and others) thereof to the subject, wherein the subject has a mutation in a DNA repair gene.

Status:
Grant
Type:

Utility

Filling date:

30 Oct 2018

Issue date:

19 Oct 2021